Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DIABETES

Can GABA turn pancreatic α-cells into β-cells?

The neurotransmitter GABA has been shown to induce the transdifferentiation of α-cells into β-cells, restoring normoglycaemia in a mouse model of diabetes mellitus. A recent paper by Amanda Ackermann and colleagues, however, failed to reproduce these findings. Here, we discuss the discrepant findings and propose a systematic approach to solve the controversy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Investigating the effect of GABA on β-like cell transdifferentiation from α-cells.

References

  1. Cnop, M. et al. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl. 2), 97–107 (2005).

    Article  Google Scholar 

  2. Cnop, M. et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53, 321–330 (2010).

    Article  CAS  Google Scholar 

  3. Courtney, M. et al. The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells. PLOS Genet 9, e1003934 (2013).

    Article  Google Scholar 

  4. Ben-Othman, N. et al. Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis. Cell 168, 73–85 (2017).

    Article  CAS  Google Scholar 

  5. Li, J. et al. Artemisins target GABA receptor signalling and impair α cell identity. Cell 168, 86–100 (2017).

    Article  CAS  Google Scholar 

  6. Gonzalez-Duque, S. et al. Conventional and neo-antigenic peptides presented by β cells are targeted by circulating naïve CD8+ cells in type 1 diabetic and healthy donors. Cell Metab. https://doi.org/10.1016/j.cmet.2018.07.007 (2018).

    Article  PubMed  Google Scholar 

  7. Skyler, J. S. Hope versus hype: where are we in type 1 diabetes? Diabetologia 61, 509–516 (2018).

    Article  Google Scholar 

  8. Van der Meulen, T. et al. Arthemer does not turn α cells into β cells. Cell Metab. 27, 1–8 (2018).

    Article  Google Scholar 

  9. Ackermann, A. M., Moss, N. G. & Kaestner, K. H. GABA and artesunate do not induce pancreatic α-to-β cell transdifferentiation in vivo. Cell Metab. https://doi.org/10.1016/j.cmet.2018.07.002 (2018).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Decio L. Eizirik or Esteban N. Gurzov.

Ethics declarations

Competing interests

D.L.E. is a co-author on Ben-Othman, N. et al. Long-term GABA administration induces α cell-mediated β-like cell neogenesis. Cell 168, 73–85 (2017), but is presently not involved in follow-up experiments on the effects of GABA on α-cell transdifferentiation; he has no other competing interests. E.N.G. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eizirik, D.L., Gurzov, E.N. Can GABA turn pancreatic α-cells into β-cells?. Nat Rev Endocrinol 14, 629–630 (2018). https://doi.org/10.1038/s41574-018-0101-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-018-0101-6

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing